Autonomix Medical Secures New U.S. Patent for Precision Neuromodulation Platform
THE WOODLANDS, Texas, July 23, 2026 Autonomix Medical, Inc. announced that it has been granted U.S. Patent No. 12,471,776,...
intellectual property
Advertisement
UroGen Secures U.S. Patent Protection for ZUSDURI Through 2044
PRINCETON, N.J., July 15, 2026 UroGen Pharma announced that the U.S. Patent and Trademark Office (USPTO) has issued a...
Can-Fite Secures Australian Patent for Namodenoson in Liver and Pancreatic Cancer
Ramat Gan, Israel, July 14, 2026 Can-Fite BioPharma announced that the Australian Patent Office has allowed Patent Application No....
Madrigal Pharmaceuticals Secures Three New Resmetirom U.S. Patents
CONSHOHOCKEN, Pa., July 13, 2026 Madrigal Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued three...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
Advertisements
Catheter Precision Wins Two Patents for VIVO and Cardionomix
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
Anixa Wins First Korean Patent for Breast Cancer Vaccine
SAN JOSE, Calif., June 29, 2026 Anixa Biosciences, Inc. announced that the Korean Ministry of Intellectual Property (MOIP) has...
Harbour BioMed Secures Major Antibody Patent Victory Over Amgen
CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...
Xeris Pharmaceuticals Receives USPTO Patent Allowance for KEVEYIS
CHICAGO, June 11, 2026 Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holdings, Inc., announced that the U.S....
Actinium Strengthens IP Portfolio for Radiotherapy Programs
NEW YORK, May 29, 2026 Actinium Pharmaceuticals, Inc. has announced the receipt of two patent allowances from the Canadian...
Advertisement
